Genmab A/S Capital Reinvestment Ratio
Genmab A/S capital reinvestment ratio. Genmab A/S (GMAB) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow (Dkr536.00 Million) in capital expenditures (Dkr2.00 Million). See Genmab A/S (GMAB) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Genmab A/S (2007–2024)
Capital reinvestment ratio of Genmab A/S from 2007 to 2024. This chart tracks Genmab A/S's Capital Reinvestment Ratio across 14 annual periods. See GMAB FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Genmab A/S Capital Reinvestment Ratio by Year (2007–2024)
Genmab A/S capital reinvestment ratio by year from 2007 to 2024. For the full cash flow conversion analysis, see GMAB operating cash flow.
| Year | Reinvestment Ratio | Operating CF (DKK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.02x | Dkr7.77 Billion | Dkr187.00 Million | ▼ -52.8% |
| 2023 | 0.05x | Dkr7.38 Billion | Dkr376.00 Million | ▼ -37.1% |
| 2022 | 0.08x | Dkr3.91 Billion | Dkr317.00 Million | ▼ -28.4% |
| 2021 | 0.11x | Dkr2.23 Billion | Dkr252.00 Million | ▲ +137.0% |
| 2020 | 0.05x | Dkr6.43 Billion | Dkr307.00 Million | ▼ -43.0% |
| 2019 | 0.08x | Dkr1.33 Billion | Dkr111.00 Million | ▼ -82.2% |
| 2018 | 0.47x | Dkr1.01 Billion | Dkr477.37 Million | ▲ +744.5% |
| 2017 | 0.06x | Dkr1.59 Billion | Dkr88.51 Million | ▼ -44.9% |
| 2016 | 0.10x | Dkr327.72 Million | Dkr33.11 Million | ▼ -76.8% |
| 2015 | 0.43x | Dkr311.45 Million | Dkr135.39 Million | ▼ -23.6% |
| 2014 | 0.57x | Dkr132.67 Million | Dkr75.44 Million | ▲ +348.2% |
| 2012 | 0.13x | Dkr70.92 Million | Dkr9.00 Million | ▲ +236.5% |
| 2010 | 0.04x | Dkr268.17 Million | Dkr10.11 Million | ▲ +48.5% |
| 2007 | 0.03x | Dkr505.90 Million | Dkr12.84 Million | — |